BMJ : British medical journal
-
Randomized Controlled Trial
Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial.
To determine whether the probiotic Lactobacillus reuteri DSM 17938 reduces crying or fussing in a broad community based sample of breastfed infants and formula fed infants with colic aged less than 3 months. ⋯ L reuteri DSM 17938 did not benefit a community sample of breastfed infants and formula fed infants with colic. These findings differ from previous smaller trials of selected populations and do not support a general recommendation for the use of probiotics to treat colic in infants.